{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:48:05Z","timestamp":1785797285279,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Connective tissue Diseases Research Center","award":["CTDRC1403.87"],"award-info":[{"award-number":["CTDRC1403.87"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10067-026-07931-4","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:14:32Z","timestamp":1769498072000},"page":"1687-1696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparing clinical outcomes of rheumatoid arthritis by onset type: palindromic rheumatism, undifferentiated arthritis, and typical rheumatoid arthritis"],"prefix":"10.1007","volume":"45","author":[{"given":"Nima","family":"Hajialilou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6967","authenticated-orcid":false,"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Hajialilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"7931_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.41417","volume":"73","author":"KD Deane","year":"2021","unstructured":"Deane KD, Holers VM (2021) Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol 73:181\u2013193. https:\/\/doi.org\/10.1002\/art.41417","journal-title":"Arthritis Rheumatol"},{"key":"7931_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0754-0","volume":"20","author":"KD Deane","year":"2018","unstructured":"Deane KD (2018) Preclinical rheumatoid arthritis and rheumatoid arthritis prevention. Curr Rheumatol Rep 20:50. https:\/\/doi.org\/10.1007\/s11926-018-0754-0","journal-title":"Curr Rheumatol Rep"},{"key":"7931_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/acr2.11086","volume":"1","author":"L Ellingwood","year":"2019","unstructured":"Ellingwood L, Schieir O, Valois MF et al (2019) Palindromic rheumatism frequently precedes early rheumatoid arthritis: results from an incident cohort. ACR Open Rheumatology 1:614\u2013619. https:\/\/doi.org\/10.1002\/acr2.11086","journal-title":"ACR Open Rheumatology"},{"key":"7931_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.reuma.2015.08.002","volume":"12","author":"H Corominas","year":"2016","unstructured":"Corominas H, Narv\u00e1ez J, D\u00edaz-Torn\u00e9 C et al (2016) Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study Reumatol Clin 12:146\u2013150. https:\/\/doi.org\/10.1016\/j.reuma.2015.08.002","journal-title":"The AUDIT study Reumatol Clin"},{"key":"7931_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41584-019-0308-5","volume":"15","author":"K Mankia","year":"2019","unstructured":"Mankia K, Emery P (2019) Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nat Rev Rheumatol 15:687\u2013695. https:\/\/doi.org\/10.1038\/s41584-019-0308-5","journal-title":"Nat Rev Rheumatol"},{"key":"7931_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheum 73:1108\u20131123. https:\/\/doi.org\/10.1002\/art.41752","journal-title":"Arthritis Rheum"},{"key":"7931_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e8 RBM, Bijlsma JWJ et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79:685\u2013699. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655","journal-title":"Ann Rheum Dis"},{"key":"7931_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/keh222","volume":"43","author":"VP Nell","year":"2004","unstructured":"Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43:906\u2013914. https:\/\/doi.org\/10.1093\/rheumatology\/keh222","journal-title":"Rheumatology (Oxford)"},{"key":"7931_CR9","doi-asserted-by":"publisher","unstructured":"van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm- Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann Rheum Dis 74:806\u2013812. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206047","DOI":"10.1136\/annrheumdis-2014-206047"},{"key":"7931_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001242","volume":"6","author":"SA Bergstra","year":"2020","unstructured":"Bergstra SA, Van Der Pol JA, Riyazi N, Goekoop-Ruiterman YPM, Kerstens PJSM, Lems W et al (2020) Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity? RMD Open 6:e001242. https:\/\/doi.org\/10.1136\/rmdopen-2020-001242","journal-title":"RMD Open"},{"key":"7931_CR11","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1007\/s10067-021-05831-3","volume":"40","author":"S Ebrahimian","year":"2021","unstructured":"Ebrahimian S, Salami A, Malek Mahdavi A, Esalatmanesh K, Khabbazi A, Hajialilo M (2021) Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study. Clin Rheumatol 40:4485\u20134491. https:\/\/doi.org\/10.1007\/s10067-021-05831-3","journal-title":"Clin Rheumatol"},{"key":"7931_CR12","first-page":"41","volume":"27","author":"L Gonzalez-Lopez","year":"2000","unstructured":"Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, Russell AS, Suarez-Almazor ME (2000) Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol 27:41\u201346","journal-title":"J Rheumatol"},{"key":"7931_CR13","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3899\/jrheum.120995","volume":"39","author":"SJ Katz","year":"2012","unstructured":"Katz SJ, Russell AS (2012) Palindromic rheumatism: a pre-rheumatoid arthritis state? J Rheumatol 39:1912\u20131913","journal-title":"J Rheumatol"},{"key":"7931_CR14","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s10067-023-06678-6","volume":"42","author":"M Mashayekhi","year":"2023","unstructured":"Mashayekhi M, Khalaji A, Malek Mahdavi A, Khabbazi A (2023) Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study. Clin Rheumatol 42:3143\u20133152. https:\/\/doi.org\/10.1007\/s10067-023-06678-6","journal-title":"Clin Rheumatol"},{"key":"7931_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.reuma.2019.01.002","volume":"17","author":"A Khabbazi","year":"2021","unstructured":"Khabbazi A, Mirza-Aghazadeh-Attari M, Goli MT, Mahdavi AM, Hajialilo M, Rashtchizadeh N (2021) Is palindromic rheumatism a pre-rheumatoid arthritis condition? Low incidence of rheumatoid arthritis in palindromic rheumatism patients treated with tight control strategy. Reumatol Clin (Engl Ed) 17:7\u201311. https:\/\/doi.org\/10.1016\/j.reuma.2019.01.002","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"7931_CR16","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10067-023-06548-1","volume":"42","author":"A Khabbazi","year":"2023","unstructured":"Khabbazi A, Gadakchi L, Moslemi M et al (2023) Prevalence and predictors of long\u2011term remission in rheumatoid arthritis in real-world practice: a longitudinal study. Clin Rheumatol 42:1537\u20131544. https:\/\/doi.org\/10.1007\/s10067-023-06548-1","journal-title":"Clin Rheumatol"},{"key":"7931_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1756-185X.2012.01739.x","volume":"15","author":"A Khabbazi","year":"2012","unstructured":"Khabbazi A, Hajialiloo M, Kolahi S, Soroosh M, Esalatmanesh K, Sharif S (2012) A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int J Rheum Dis 15:427\u2013430. https:\/\/doi.org\/10.1111\/j.1756-185X.2012.01739.x","journal-title":"Int J Rheum Dis"},{"key":"7931_CR18","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62\u201367","journal-title":"J Rheumatol"},{"issue":"Suppl 6","key":"7931_CR19","doi-asserted-by":"publisher","first-page":"vi16","DOI":"10.1093\/rheumatology\/kes281","volume":"51","author":"VP Bykerk","year":"2012","unstructured":"Bykerk VP, Massarotti EM (2012) The new ACR\/EULAR remission criteria: rationale for developing new criteria for remission. Rheumatology (Oxford) 51(Suppl 6):vi16-20. https:\/\/doi.org\/10.1093\/rheumatology\/kes281","journal-title":"Rheumatology (Oxford)"},{"key":"7931_CR20","first-page":"540","volume":"26","author":"L Gonzalez-Lopez","year":"1999","unstructured":"Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, Ramos-Remus C, Russell AS, Suarez-Almazor ME (1999) Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol 26:540\u2013545","journal-title":"J Rheumatol"},{"key":"7931_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00296-017-3661-1","volume":"37","author":"S Kolahi","year":"2017","unstructured":"Kolahi S, Khabbazi A, Malek Mahdavi A et al (2017) Prevalence of musculoskeletal disorders in Azar cohort population in Northwest of Iran. Rheumatol Int 37:495\u2013502. https:\/\/doi.org\/10.1007\/s00296-017-3661-1","journal-title":"Rheumatol Int"},{"key":"7931_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105128","volume":"88","author":"JK Ahn","year":"2021","unstructured":"Ahn JK, Hwang J, Hyeon Seo G (2021) Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: a nationwide population-based study. Joint Bone Spine 88:105128. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105128","journal-title":"Joint Bone Spine"},{"key":"7931_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bmj.2.5858.96","volume":"2","author":"RK Jacoby","year":"1973","unstructured":"Jacoby RK, Jayson MI, Cosh JA (1973) Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. BMJ 2:96\u2013100. https:\/\/doi.org\/10.1136\/bmj.2.5858.96","journal-title":"BMJ"},{"issue":"5","key":"7931_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3899\/jrheum.190061","volume":"47","author":"R Castellanos-Moreira","year":"2020","unstructured":"Castellanos-Moreira R, Rodriguez-Garcia SC, G\u00f3mez-Puerta JA et al (2020) Rheumatoid arthritis initiating as palindromic rheumatism: a distinct clinical phenotype? J Rheumatol 47(5):652\u2013657. https:\/\/doi.org\/10.3899\/jrheum.190061","journal-title":"J Rheumatol"},{"key":"7931_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.autrev.2011.10.019","volume":"11","author":"I Olivieri","year":"2012","unstructured":"Olivieri I, Sarzi-Puttini P, Bugatti S, Atzeni F, d\u2019Angelo S, Caporali R (2012) Early treatment in early undifferentiated arthritis. Autoimmun Rev 11:589\u2013592. https:\/\/doi.org\/10.1016\/j.autrev.2011.10.019","journal-title":"Autoimmun Rev"},{"key":"7931_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.657983","volume":"8","author":"R Sanmart\u00ed","year":"2021","unstructured":"Sanmart\u00ed R, Frade-Sosa B, Morl\u00e0 R et al (2021) Palindromic rheumatism: just a pre-rheumatoid stage or something else? Front Med (Lausanne) 8:657983. https:\/\/doi.org\/10.3389\/fmed.2021.657983","journal-title":"Front Med (Lausanne)"},{"key":"7931_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3899\/jrheum.090025","volume":"36","author":"E Koskinen","year":"2009","unstructured":"Koskinen E, Hannonen P, Sokka T (2009) Palindromic rheumatism: long-term outcomes of 60 patients diagnosed in 1967\u201384. J Rheumatol 36:1873\u20131875. https:\/\/doi.org\/10.3899\/jrheum.090025","journal-title":"J Rheumatol"},{"key":"7931_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10067-014-2649-4","volume":"8","author":"S Cabrera-Villalba","year":"2013","unstructured":"Cabrera-Villalba S, Sanmart\u00ed R (2013) Palindromic rheumatism: a reappraisal. Int J Clin Rheumatol 8:569\u2013577. https:\/\/doi.org\/10.1007\/s10067-014-2649-4","journal-title":"Int J Clin Rheumatol"},{"key":"7931_CR29","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/keg268","volume":"42","author":"G Salvador","year":"2003","unstructured":"Salvador G, Gomez A, Vi\u00f1as O et al (2003) Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism: an abortive form of rheumatoid arthritis. Rheumatology (Oxford) 42:972\u2013975. https:\/\/doi.org\/10.1093\/rheumatology\/keg268","journal-title":"Rheumatology (Oxford)"},{"key":"7931_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/03009741003604534","volume":"39","author":"M Tamai","year":"2010","unstructured":"Tamai M, Kawakami A, Iwamoto N, Arima K, Aoyagi K, Eguchi K (2010) Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Scand J Rheumatol 39:287\u2013291. https:\/\/doi.org\/10.3109\/03009741003604534","journal-title":"Scand J Rheumatol"},{"key":"7931_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/labmed\/lmaa095","volume":"52","author":"A Malek Mahdavi","year":"2021","unstructured":"Malek Mahdavi A, Rashtchizadeh N, Khaknejad M, Sakhinia E, Khabbazi A, Kolahi S (2021) Clinical significance of anti-modified citrullinated vimentin antibodies in palindromic rheumatism. Lab Med 52:357\u2013363. https:\/\/doi.org\/10.1093\/labmed\/lmaa095","journal-title":"Lab Med"},{"key":"7931_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108378","volume":"102","author":"A Malek Mahdavi","year":"2022","unstructured":"Malek Mahdavi A, Rahmanpour D, Dehgan M, Pahlavan Y, Mahmoudi M, Khabbazi A (2022) Cigarette smoking and risk of palindromic rheumatism: a propensity score matching analysis. Int Immunopharmacol 102:108378. https:\/\/doi.org\/10.1016\/j.intimp.2021.108378","journal-title":"Int Immunopharmacol"},{"key":"7931_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/labmed\/lmad032","volume":"55","author":"A Khabbazi","year":"2024","unstructured":"Khabbazi A, Mahmoudi M, Esalatmanesh K, Asgari-Sabet M, Safary A (2024) Vitamin D status in palindromic rheumatism: a propensity score matching analysis. Lab Med 55:45\u201349. https:\/\/doi.org\/10.1093\/labmed\/lmad032","journal-title":"Lab Med"},{"key":"7931_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/annrheumdis-2018-214175","volume":"78","author":"K Mankia","year":"2019","unstructured":"Mankia K, D\u2019Agostino MA, Wakefield RJ, Nam JL, Mahmood W, Grainger AJ, Emery P (2019) Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Ann Rheum Dis 78:43\u201350. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214175","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7931_CR35","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/art.22755","volume":"56","author":"JD Ca\u00f1ete","year":"2007","unstructured":"Ca\u00f1ete JD, Arostegui JI, Queir\u00f3 R et al (2007) An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum 56(8):2784\u20132788. https:\/\/doi.org\/10.1002\/art.22755","journal-title":"Arthritis Rheum"},{"key":"7931_CR36","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/art.42614","volume":"75","author":"C Zheng","year":"2023","unstructured":"Zheng C, Wang F, Sun Y et al (2023) Identification of distinct genetic profiles of palindromic rheumatism using whole-exome sequencing. Arthritis Rheumatol 75:1947\u20131957. https:\/\/doi.org\/10.1002\/art.42614","journal-title":"Arthritis Rheumatol"},{"key":"7931_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15280","volume":"27","author":"S Shahmohammadi-Farid","year":"2024","unstructured":"Shahmohammadi-Farid S, Asgharvand-Hajeb A, Javidi-Aghdam K, Jafarpour M, Khabbazi A (2024) Frequency of HLA-DRB1 alleles in palindromic rheumatism in the Azeri population. Int J Rheum Dis 27:e15280. https:\/\/doi.org\/10.1111\/1756-185X.15280","journal-title":"Int J Rheum Dis"},{"key":"7931_CR38","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1007\/s10067-025-07652-0","volume":"44","author":"A Asgharvand-Hajeb","year":"2025","unstructured":"Asgharvand-Hajeb A, Shahmohammadi-Farid S, Saberivand M et al (2025) Molecular analysis of TNFAIP3, PTPN22, IRF5, and IL-10 gene polymorphisms in palindromic rheumatism. Clin Rheumatol 44:4759\u20134766. https:\/\/doi.org\/10.1007\/s10067-025-07652-0","journal-title":"Clin Rheumatol"},{"key":"7931_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2005.038471","volume":"65","author":"J van Aken","year":"2006","unstructured":"van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TWJ (2006) Comparison of long-term outcome of patients with undifferentiated arthritis and rheumatoid arthritis that started treatment with DMARDs. Ann Rheum Dis 65:20\u201325. https:\/\/doi.org\/10.1136\/ard.2005.038471","journal-title":"Ann Rheum Dis"},{"key":"7931_CR40","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/art.22525","volume":"56","author":"H van Dongen","year":"2007","unstructured":"van Dongen H, van Aken J, Lard LR et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56:1424\u20131432. https:\/\/doi.org\/10.1002\/art.22525","journal-title":"Arthritis Rheum"},{"key":"7931_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357\u2013365. https:\/\/doi.org\/10.1002\/art.10117","journal-title":"Arthritis Rheum"},{"key":"7931_CR42","doi-asserted-by":"publisher","unstructured":"van der Helm- Mil AHM, le Cessie S, van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56:433\u2013440. https:\/\/doi.org\/10.1002\/art.22380","DOI":"10.1002\/art.22380"},{"key":"7931_CR43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00296-024-05762-7","volume":"43","author":"RJ Wakefield","year":"2000","unstructured":"Wakefield RJ, O\u2019Connor PJ, Conaghan PG, Fredberg U, Ellingsen T (2000) Finger joint synovitis in untreated early rheumatoid arthritis: detection by ultrasound and magnetic resonance imaging. Arthritis Rheum 43:1237\u20131249. https:\/\/doi.org\/10.1007\/s00296-024-05762-7","journal-title":"Arthritis Rheum"},{"key":"7931_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/ard.2009.125534","volume":"67","author":"ML Hetland","year":"2008","unstructured":"Hetland ML, Stengaard-Pedersen K, Junker P et al (2008) Radiographic progression and remission rates in early rheumatoid arthritis: MRI and ultrasound findings in the CIMESTRA cohort. Ann Rheum Dis 67:857\u2013863. https:\/\/doi.org\/10.1136\/ard.2009.125534","journal-title":"Ann Rheum Dis"},{"key":"7931_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"DPC de Rooy","year":"2011","unstructured":"de Rooy DPC, van der Linden MPM, Knevel R et al (2011) Predicting arthritis outcomes: what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 50:93\u2013100. https:\/\/doi.org\/10.1093\/rheumatology\/keq230","journal-title":"Rheumatology (Oxford)"},{"key":"7931_CR46","doi-asserted-by":"publisher","unstructured":"van Steenbergen HW, van Nies JAB, Huizinga TWJ, Bloem JL, Reijnierse M, van der Helm- Mil AHM (2015) Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI. Ann Rheum Dis 74:1225\u20131232. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205522","DOI":"10.1136\/annrheumdis-2014-205522"},{"key":"7931_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/ar4498","volume":"16","author":"D Di Giuseppe","year":"2014","unstructured":"Di Giuseppe D, Discacciati A, Orsini N, Wolk A (2014) Cigarette smoking and risk of rheumatoid arthritis: a dose\u2013response meta-analysis. Arthritis Res Ther 16:R61. https:\/\/doi.org\/10.1186\/ar4498","journal-title":"Arthritis Res Ther"},{"key":"7931_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10786-8","volume":"52","author":"K Javidi-Aghdam","year":"2025","unstructured":"Javidi-Aghdam K, Akbarzadeh-Khiavi M, Ghasembaglou A et al (2025) Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis. Mol Biol Rep 52:672. https:\/\/doi.org\/10.1007\/s11033-025-10786-8","journal-title":"Mol Biol Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07931-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T04:11:14Z","timestamp":1775448674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07931-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7931"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07931-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in compliance with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}